Evidence map›Paper›PMID 25971680›Full record

Observational studyBMC family practice2015

Psychological impact of lifestyle-related disease disclosure at general checkup: a prospective cohort study.

Tomokazu Tominaga, Masato Matsushima, Takuya Nagata, Akinari Moriya, Takamasa Watanabe, Yuko Nakano, Yoko Hirayama, Yasuki Fujinuma

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC family practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Tomokazu TominagaMusashi-Koganei Clinic, Japanese Health and Welfare Co-operative Federation, 1-15-9 Honcho koganeishi, 181-0004, Tokyo, Japan. littlemuffinbaby@gmail.com.
Masato MatsushimaDivision of Clinical Epidemiology, Jikei University School of Medicine, 3-25-8 Nishishimbachi, 105-8461, Minato-ku, Tokyo, Japan. masato@jikei.ac.jp.
Takuya NagataDivision of Clinical Epidemiology, Jikei University School of Medicine, 3-25-8 Nishishimbachi, 105-8461, Minato-ku, Tokyo, Japan. taku8nagata@gmail.com.
Akinari MoriyaDivision of Clinical Epidemiology, Jikei University School of Medicine, 3-25-8 Nishishimbachi, 105-8461, Minato-ku, Tokyo, Japan. moriya.akinari@gmail.com.
Takamasa WatanabeKita-Adachi Seikyo Clinic, Tokyo Hokuto Health Co-operative, 3-1-5 Iriya, 121-0836, Adachi-ku, Tokyo, Japan. watanabetakamasa@gmail.com.
Yuko NakanoJapan Small Animal Cancer Center, 2-27-4 Nakatomiminami, 359-0003, Tokorozawa, Saitama, Japan. yuko-n@momo.so-net.ne.jp.
Yoko HirayamaOji Seikyo Hospital, Tokyo Hokuto Health Co-operative, 3-4-15 Toshima, 114-0003, Kita-ku, Tokyo, Japan. yokohira7@gmail.com.
Yasuki FujinumaCentre for Family Medicine Development, Japanese Health and Welfare Co-operative Federation, 3-22-1 Ukima, 115-0051, Kita-ku, Tokyo, Japan. yasukifujinuma@gmail.com.
Jikei University School of Medicine · JPChiba University · JPJapan Small Animal Medical Center · JPKoga Hospital · JPSeiko Holdings (Japan) · JPToshima Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLittle is known about psychological impact of disclosing lifestyle-related diseases. Previous studies discussed the long-term psychological impact of disease disclosure, and a significant psychological impact was not observed. This study clarified the psychological impact on anxiety state of patients when lifestyle-related diseases are disclosed at general checkups for local residents. In particular, this study evaluated the short-term impact on patients, and how the notification of abnormal values and the disclosure of disease at general checkups affect patients' subsequent behavioral changes.

methodsThe study design was a prospective cohort study. We compared the anxiety state of participants using a self-administered anxiety assessment scale, State-Trait Anxiety Inventory (STAI), before and after Physician's explanation of abnormal values in markers of lifestyle-related diseases. The participants were those between the age of 40 and 75 years who underwent general checkups at two primary care facilities. In addition, we assessed the effects on lifestyle habits and the psychological impact caused by general checkup using STAI and a survey on behavioral changes one month after the checkup.

resultsThe valid response rate at the survey of the general checkup was 92% (534/578). Of those who showed abnormal levels in markers of lifestyle-related diseases, anxiety was augmented significantly among those who responded that the physician had told them of their diagnosis compared to those who responded that the physician had not told them of their diagnosis (Wilcoxon rank-sum test, P < 0.007). The percentage of patients whose state anxiety scale of STAI increased ≥5 points was 30% in the disease disclosed group (33/111) and 17% in the disease undisclosed group (27/159), respectively. The risk ratio was 1.5 (95% CI: 1.1-2.0). One month after the general checkup, overall anxiety diminished regardless of whether diagnosis of lifestyle-related diseases was disclosed to patients notified of abnormal values. In addition, improvements in daily life behaviors as a result of notification of abnormalities or disclosure of diagnosis at general checkup were not observed.

conclusionEven in a general checkup for the general population, disclosing non-critical diseases such as lifestyle-related diseases exacerbated anxiety as a short-term psychological impact.

Indexed as

AnxietyLife StyleTruth DisclosureAdaptation, PsychologicalAgedAttitude to HealthCohort StudiesDiabetes MellitusDyslipidemiasFemaleHumansHypertensionJapanMaleMiddle AgedPrimary Health Care

Identifiers

PMID25971680
PMCPMC4437684
OpenAlexW1572990080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.